A Practical Guide for Treatment of Rapidly Progressive ADPKD with Tolvaptan.
Chebib FT, Perrone RD, Chapman AB, Dahl NK, Harris PC, Mrug M, Mustafa RA, Rastogi A, Watnick T, Yu ASL, Torres VE.
J Am Soc Nephrol. 2018 Oct;29(10):2458-2470. doi: 10.1681/ASN.2018060590. Epub 2018 Sep 18.
IgA Nephropathy: Core Curriculum 2021.
Pattrapornpisut P, Avila-Casado C, Reich HN.
Am J Kidney Dis. 2021 Sep;78(3):429-441. doi: 10.1053/j.ajkd.2021.01.024. Epub 2021 Jul 9.
Goodpasture syndrome and anti-glomerular basement membrane disease.
Reggiani F, L'Imperio V, Calatroni M, Pagni F, Sinico RA.
Clin Exp Rheumatol. 2023 Apr;41(4):964-974. doi: 10.55563/clinexprheumatol/tep3k5. Epub 2023 Mar 30.
Nephrotic syndrome: pathophysiology and consequences.
Claudio P, Gabriella M.
J Nephrol. 2023 Nov;36(8):2179-2190. doi: 10.1007/s40620-023-01697-7. Epub 2023 Jul 19.
Anti-Glomerular Basement Membrane Disease.
McAdoo SP, Pusey CD.
Clin J Am Soc Nephrol. 2017 Jul 7;12(7):1162-1172. doi: 10.2215/CJN.01380217. Epub 2017 May 17.
Diagnosis and classification of Goodpasture's disease (anti-GBM).
Hellmark T, Segelmark M.
J Autoimmun. 2014 Feb-Mar;48-49:108-12. doi: 10.1016/j.jaut.2014.01.024. Epub 2014 Jan 21.
Treatment of IgA Nephropathy: A Rapidly Evolving Field.
El Karoui K, Fervenza FC, De Vriese AS.
J Am Soc Nephrol. 2024 Jan 1;35(1):103-116. doi: 10.1681/ASN.0000000000000242. Epub 2023 Sep 29.
Podocyte-Parietal Epithelial Cell Interdependence in Glomerular Development and Disease.
Bronstein R, Pace J, Gowthaman Y, Salant DJ, Mallipattu SK.
J Am Soc Nephrol. 2023 May 1;34(5):737-750. doi: 10.1681/ASN.0000000000000104. Epub 2023 Feb 16.
From AKI to CKD: Maladaptive Repair and the Underlying Mechanisms.
Wang Z, Zhang C.
Int J Mol Sci. 2022 Sep 17;23(18):10880. doi: 10.3390/ijms231810880.
Assessing Risk of Rapid Progression in Autosomal Dominant Polycystic Kidney Disease and Special Considerations for Disease-Modifying Therapy.
Chebib FT, Torres VE.
Am J Kidney Dis. 2021 Aug;78(2):282-292. doi: 10.1053/j.ajkd.2020.12.020. Epub 2021 Mar 8.
